Benzinga | May 25, 2021 06:59AM EDT

Raymond James Downgrades 89bio to Outperform, Lowers Price Target to $35

Raymond James analyst Steven Seedhouse downgrades 89bio (NASDAQ:ETNB) from Strong Buy to Outperform and lowers the price target from $65 to $35.